Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor–Resistant Clear Cell Renal Cell Carcinoma
2017 ◽
Vol 10
(3)
◽
pp. 304-310
◽
2014 ◽
Vol 55
(2)
◽
pp. 242-247
◽
2014 ◽
Vol 20
(2)
◽
pp. 351-357
◽
2012 ◽
Vol 55
(11)
◽
pp. 717
◽
2015 ◽
Vol 77
(2)
◽
pp. 339-347
◽